<p>Tilray（纳斯达克代码：TLRY - 获取免费报告）预计将在 4 月 8 日星期二市场开盘前公布其财报。分析师预计该公司本季度每股收益为（$0.04），收入为 2.1338 亿美元。Tilray 已将其 2025 财年的指引设定为每股收益。</p>
<ul>
<li>寻求稳定？这三只股票提供强劲潜力</li>
</ul>
<p>Tilray（纳斯达克代码：TLRY - 获取免费报告）上一次公布财报是在 1 月 10 日星期五。该公司报告本季度每股收益为（$0.10），低于分析师一致预期的（$0.03），差距为（$0.07）。该公司本季度的收入为 2.109 亿美元，而分析师预期为 2.1634 亿美元。Tilray 的净利润率为负 30.95%，股本回报率为负 4.40%。与去年同期相比，该公司的季度收入增长了 8.7%。分析师平均预计 Tilray 在当前财年的每股收益为$0，在下一个财年的每股收益也为$0。</p>
<h2>Tilray 股价下跌 0.8%</h2>
<p>TLRY 股票在星期二开盘时为$0.66。该公司的 50 日移动平均为$0.84，200 日移动平均为$1.25。该公司的市值为 6.1651 亿美元，市盈率为-2.19，贝塔值为 2.13。Tilray 的 1 年最低价为$0.58，最高价为$2.97。该公司的债务与股本比率为 0.10，流动比率为 2.54，速动比率为 1.58。</p>
<h2>分析师评级上调与下调</h2>
<ul>
<li>大麻股票：该行业的变革性催化剂？</li>
</ul>
<p>另外，Canaccord Genuity Group 在 1 月 13 日星期一的报告中将 Tilray 的目标价从$2.00 上调至$3.00，并给予该公司 “买入” 评级。三位投资分析师对该股票给予持有评级，两位分析师给予买入评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “持有”，共识目标价为$2.70。</p>
<p><strong>阅读我们最新的 TLRY 股票分析</strong></p>
<h2>Tilray 公司简介</h2>
<p>（获取免费报告）</p>
<ul>
<li>Tilray 的第三季度财报显示尽管面临挑战仍有增长</li>
</ul>
<p>Tilray, Inc 从事医疗大麻的研究、种植、加工和分销。该公司的产品在阿根廷、澳大利亚、加拿大、智利、克罗地亚、塞浦路斯、捷克共和国、德国、新西兰和南非销售。Tilray, Inc 总部位于加拿大。</p>
<h2>阅读更多</h2>
<ul>
<li>五只我们更看好的股票，胜过 Tilray</li>
<li>最具波动性的股票，投资者需要知道的事项</li>
<li>三只可买入的股票，底部坚实，准备反弹</li>
<li>你应该将这些沃伦·巴菲特的股票加入你的投资组合吗？</li>
<li>Advantage+ 购物：Meta 快速增长的 200 亿美元 AI 广告明星</li>
<li>投资者需要了解即将上市的 IPO</li>
<li>Robotaxi 新闻：特斯拉和 Lyft 的头条对股票的影响</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VExSWQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VExSWQ"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 在 Tilray 吗？</h2>
<p>在你考虑 Tilray 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前立即购买……而 Tilray 并不在名单上。</p>
<p>虽然 Tilray 目前在分析师中获得 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

TLRY

<p>Tilray（纳斯达克代码：TLRY）将于 4 月 8 日公布季度财报，分析师预计每股亏损 0.04 美元，收入为 2.1338 亿美元。该公司此前报告每股亏损 0.10 美元，未能达到预期。Tilray 的股票目前交易价格为 0.66 美元，市值为 6.1651 亿美元。分析师对 Tilray 的共识评级为 “持有”，目标价格为 2.70 美元。Canaccord Genuity 最近将其目标价格从 2.00 美元上调至 3.00 美元，并维持 “买入” 评级</p>

<p>Tilray (NASDAQ:TLRY - Get Free Report) is projected to announce its earnings results before the market opens on Tuesday, April 8th. Analysts expect the company to announce earnings of ($0.04) per share and revenue of $213.38 million for the quarter. Tilray has set its FY 2025 guidance at EPS.</p>
<div class="lb-trans"><p>Tilray（纳斯达克代码：TLRY - 获取免费报告）预计将在 4 月 8 日星期二市场开盘前公布其财报。分析师预计该公司本季度每股收益为（$0.04），收入为 2.1338 亿美元。Tilray 已将其 2025 财年的指引设定为每股收益。</p>
</div><ul>
<li>Seeking Stability? These 3 Stocks Offer Strong Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>寻求稳定？这三只股票提供强劲潜力</li>
</ul>
</div><p>Tilray (NASDAQ:TLRY - Get Free Report) last posted its earnings results on Friday, January 10th. The company reported ($0.10) EPS for the quarter, missing analysts' consensus estimates of ($0.03) by ($0.07). The company had revenue of $210.90 million during the quarter, compared to analyst estimates of $216.34 million. Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The firm's quarterly revenue was up 8.7% compared to the same quarter last year. On average, analysts expect Tilray to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.</p>
<div class="lb-trans"><p>Tilray（纳斯达克代码：TLRY - 获取免费报告）上一次公布财报是在 1 月 10 日星期五。该公司报告本季度每股收益为（$0.10），低于分析师一致预期的（$0.03），差距为（$0.07）。该公司本季度的收入为 2.109 亿美元，而分析师预期为 2.1634 亿美元。Tilray 的净利润率为负 30.95%，股本回报率为负 4.40%。与去年同期相比，该公司的季度收入增长了 8.7%。分析师平均预计 Tilray 在当前财年的每股收益为$0，在下一个财年的每股收益也为$0。</p>
</div><h2>Tilray Trading Down 0.8 %</h2>
<div class="lb-trans"><h2>Tilray 股价下跌 0.8%</h2>
</div><p>Shares of TLRY stock opened at $0.66 on Tuesday. The company has a 50-day moving average of $0.84 and a two-hundred day moving average of $1.25. The firm has a market cap of $616.51 million, a PE ratio of -2.19 and a beta of 2.13. Tilray has a 1-year low of $0.58 and a 1-year high of $2.97. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.54 and a quick ratio of 1.58.</p>
<div class="lb-trans"><p>TLRY 股票在星期二开盘时为$0.66。该公司的 50 日移动平均为$0.84，200 日移动平均为$1.25。该公司的市值为 6.1651 亿美元，市盈率为-2.19，贝塔值为 2.13。Tilray 的 1 年最低价为$0.58，最高价为$2.97。该公司的债务与股本比率为 0.10，流动比率为 2.54，速动比率为 1.58。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级上调与下调</h2>
</div><ul>
<li>Cannabis Stocks: Game-Changing Catalyst for the Sector?</li>
</ul>
<div class="lb-trans"><ul>
<li>大麻股票：该行业的变革性催化剂？</li>
</ul>
</div><p>Separately, Canaccord Genuity Group lifted their target price on shares of Tilray from $2.00 to $3.00 and gave the company a &#34;buy&#34; rating in a report on Monday, January 13th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of &#34;Hold&#34; and a consensus price target of $2.70.</p>
<div class="lb-trans"><p>另外，Canaccord Genuity Group 在 1 月 13 日星期一的报告中将 Tilray 的目标价从$2.00 上调至$3.00，并给予该公司 “买入” 评级。三位投资分析师对该股票给予持有评级，两位分析师给予买入评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “持有”，共识目标价为$2.70。</p>
</div><p><strong>Read Our Latest Stock Analysis on TLRY</strong></p>
<div class="lb-trans"><p><strong>阅读我们最新的 TLRY 股票分析</strong></p>
</div><h2>Tilray Company Profile</h2>
<div class="lb-trans"><h2>Tilray 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><ul>
<li>Tilray’s Q3 Earnings Reveal Growth Despite Challenges</li>
</ul>
<div class="lb-trans"><ul>
<li>Tilray 的第三季度财报显示尽管面临挑战仍有增长</li>
</ul>
</div><p>Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.</p>
<div class="lb-trans"><p>Tilray, Inc 从事医疗大麻的研究、种植、加工和分销。该公司的产品在阿根廷、澳大利亚、加拿大、智利、克罗地亚、塞浦路斯、捷克共和国、德国、新西兰和南非销售。Tilray, Inc 总部位于加拿大。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>阅读更多</h2>
</div><ul>
<li>Five stocks we like better than Tilray</li>
<li>Most Volatile Stocks, What Investors Need to Know</li>
<li>3 Buyable Stocks With Solid Bottoms Ready to Rebound</li>
<li>Should You Add These Warren Buffett Stocks to Your Portfolio?</li>
<li>Advantage+ Shopping: Meta's Fast Growing $20 Billion AI-Ads Star</li>
<li>What Investors Need to Know About Upcoming IPOs</li>
<li>Robotaxi News: What Tesla and Lyft Headlines Mean for Shares</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Tilray</li>
<li>最具波动性的股票，投资者需要知道的事项</li>
<li>三只可买入的股票，底部坚实，准备反弹</li>
<li>你应该将这些沃伦·巴菲特的股票加入你的投资组合吗？</li>
<li>Advantage+ 购物：Meta 快速增长的 200 亿美元 AI 广告明星</li>
<li>投资者需要了解即将上市的 IPO</li>
<li>Robotaxi 新闻：特斯拉和 Lyft 的头条对股票的影响</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VExSWQ" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=TLRY"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Tilray Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在 Tilray 吗？</h2>
</div><p>Before you consider Tilray, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Tilray 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前立即购买……而 Tilray 并不在名单上。</p>
</div><p>While Tilray currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Tilray 目前在分析师中获得 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Tilray Brands (TLRY) 预计将在周二公布季度财报